Parallel Advisors’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$194 Hold
60
﹤0.01% 3852
2026
Q1
$148 Hold
60
﹤0.01% 3769
2025
Q4
$123 Hold
60
﹤0.01% 3542
2025
Q3
$208 Hold
60
﹤0.01% 3437
2025
Q2
$132 Hold
60
﹤0.01% 3443
2025
Q1
$70 Hold
60
﹤0.01% 3453
2024
Q4
$76 Hold
60
﹤0.01% 3461
2024
Q3
$205 Sell
60
-175
-74% -$762 ﹤0.01% 3297
2024
Q2
$1.1K Sell
235
-138
-37% -$778 ﹤0.01% 2932
2024
Q1
$2.77K Sell
373
-13
-3% -$108 ﹤0.01% 2724
2023
Q4
$3.91K Buy
386
+293
+315% +$2.57K ﹤0.01% 2591
2023
Q3
$725 Hold
93
﹤0.01% 3034
2023
Q2
$765 Hold
93
﹤0.01% 2997
2023
Q1
$674 Buy
93
+43
+86% +$382 ﹤0.01% 3043
2022
Q4
$444 Hold
50
﹤0.01% 3049
2022
Q3
$1K Hold
50
﹤0.01% 2889
2022
Q2
$1K Buy
+50
New +$670 ﹤0.01% 2746
2022
Q1
Sell
-139
Closed -$4K 3042
2021
Q4
$4K Buy
139
+8
+6% +$275 ﹤0.01% 2468
2021
Q3
$5K Hold
131
﹤0.01% 2343
2021
Q2
$7K Sell
131
-55
-30% -$2.03K ﹤0.01% 2152
2021
Q1
$8K Sell
186
-20
-10% -$1.14K ﹤0.01% 2005
2020
Q4
$14K Buy
206
+112
+119% +$4.6K ﹤0.01% 1639
2020
Q3
$3K Hold
94
﹤0.01% 2177
2020
Q2
$2K Buy
+94
New +$2.46K ﹤0.01% 2180
2019
Q2
Sell
-105
Closed -$3K 2342
2019
Q1
$3K Buy
+105
New +$2.38K ﹤0.01% 1955

Other funds holding EDIT

Parallel Advisors's EDIT Position: Q2 2026 in Review

Parallel Advisors held its Editas Medicine (EDIT) position steady in Q2 2026 at 60 shares worth $194. The position accounts for ﹤0.01% of the portfolio, ranked #3852.

Parallel Advisors first reported a position in EDIT in Q1 2019 and has held it in 25 quarters since. The position peaked at $14K in Q4 2020. 79 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Parallel Advisors held 60 shares of Editas Medicine worth $194 as of Q2 2026.
  • Parallel Advisors left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3852 holding.
  • Parallel Advisors first reported a position in Editas Medicine in Q1 2019 and has held it in 25 quarters since.
  • Parallel Advisors's Editas Medicine position peaked at $14K in Q4 2020.
  • 79 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.